These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2564000)

  • 21. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.
    Honess DJ; Bleehen NM
    Br J Cancer; 1982 Aug; 46(2):236-48. PubMed ID: 6758828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
    Umeda Y; Sakamoto A; Nakamura J; Ishitsuka H; Yagi Y
    Cancer Immunol Immunother; 1983; 15(2):78-83. PubMed ID: 6553515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.
    Koç ON; Reese JS; Davis BM; Liu L; Majczenko KJ; Gerson SL
    Hum Gene Ther; 1999 Apr; 10(6):1021-30. PubMed ID: 10223735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of H2-receptor antagonists on the pharmacokinetics of 5-fluorouracil in the rat and monkey.
    Dilloway MR; Lant AF
    Biopharm Drug Dispos; 1991; 12(1):17-28. PubMed ID: 1674889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS; Fischer PH; Marsh JC; Prusoff WH
    Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of intracranial and intraperitoneal O6-benzyl guanine in combination with BCNU delivered locally in a mouse model.
    Guarnieri M; Biser-Rohrbaugh A; Tyler BM; Gabikian P; Bunton TE; Wu QZ; Weingart J; Carson BS
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):392-6. PubMed ID: 12439597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Mannich bases of styryl ketones and related hydrazones for activity against P388 leukemia.
    Dimmock JR; Jonnalagadda SS; Leek DM; Warrington RC; Fang WD
    Neoplasma; 1988; 35(6):715-24. PubMed ID: 3221938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
    Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC
    J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.
    Schmalbach TK; Borch RF
    Cancer Res; 1989 May; 49(10):2574-7. PubMed ID: 2540902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoprotection by somatostatin of normal and malignant clonogenic cells against the in vitro cytotoxicity of bischloroethylnitrosourea (BCNU).
    Maurer HR; Meckert C; Ali-Osman F; Musil J
    Arzneimittelforschung; 1984; 34(9):939-43. PubMed ID: 6150718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.
    Gerson SL; Zborowska E; Norton K; Gordon NH; Willson JK
    Biochem Pharmacol; 1993 Jan; 45(2):483-91. PubMed ID: 8435098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.
    Panasci LC; Dufour M; Chevalier L; Isabel G; Lazarus P; McQuillan A; Arbit E; Brem S; Feindel W
    Cancer Chemother Pharmacol; 1985; 14(2):156-9. PubMed ID: 3971480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of allopurinol on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2790-4. PubMed ID: 1277189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Dolan ME; Pegg AE; Moschel RC; Grindey GB
    Biochem Pharmacol; 1993 Jul; 46(2):285-90. PubMed ID: 8347150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of H2-receptor antagonists on prolactin secretion: specificity and mediation of the response.
    Knigge U; Matzen S; Warberg J
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):461-8. PubMed ID: 2888250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
    Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
    Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.